AMY GOODRICH: Open Payments
NPI 1649224916 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,703 in 4 payments from 4 companies in 2025. Trend: 2023 $4,525 · 2024 $2,422 · 2025 $2,703
Consulting: $2,446Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly and Company | 1 | $1,650 |
| Genmab U.S., Inc. | 1 | $796 |
| Janssen Biotech, Inc. | 1 | $132 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $125 |
Products named: JAYPIRCA, Epkinly, RYBREVANT.
Industry payments across MD — which companies pay providers there.
